Physalin B attenuates liver fibrosis via suppressing LAP2α–HDAC1‐mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation-Reference-Cited by-同舟云学术

Physalin B attenuates liver fibrosis via suppressing LAP2α–HDAC1‐mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation

Published:2021-05-21 Issue:17 Volume:178 Page:3428-3447
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Zhu Xiaoyun¹,Ye Shengtao¹,Yu Dongke²,Zhang Yanqiu¹,Li Jie¹,Zhang Meihui¹,Leng Yingrong¹,Yang Ting¹,Luo Jianguang¹,Chen Xinlin¹,Zhang Hao¹^ORCID,Kong Lingyi¹

Affiliation:

1. State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Bioactive Natural Product Research, School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing China

2. Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People's Hospital, School of Medicine University of Electronic Science and Technology of China Chengdu China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15490

Reference53 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes